{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:40:51Z","timestamp":1793418051556,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012921","name":"Royal College of Surgeons in Ireland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Approximately 1 in 5 patients with autosomal dominant polycystic kidney disease (ADPKD) will undergo a native nephrectomy in their lifetime. These can be emergent or planned and the indications can range from space for kidney transplant, pain, hematuria and frequent urinary tract infections (UTIs). Due to the diverse nature of presentations, there is a lack of certainty about outcomes and optimal management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>This study aimed to evaluate preoperative indications and perioperative\/postoperative complications in this patient cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective review included 41 patients with ADPKD who underwent unilateral or bilateral nephrectomy in a single hospital between 2010 and 2020. We collected data on patient demographics, surgical indications, histological results and postoperative complications. We sourced this information using the hospital\u2019s patient medical records.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The main indications for nephrectomy were pain (39.5%) and bleeding (41.8%). Further indications included recurrent UTIs (16.3%), space for transplantation (27.9%), query malignancy (4.7%) and compressive gastropathy (2.3%). With regard to side, 55.8% were right-sided, 23.3% were left-sided, and 20.9% were bilateral. Seven percent of nephrectomy specimens demonstrated malignancy. Postoperative morbidity included requiring blood transfusion and long hospital stay. Thirty-seven percent of patients received a postoperative blood transfusion. There was no immediate or postoperative mortality associated with any of the cases reviewed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In conclusion, this study demonstrates that native nephrectomy remains a safe operation for patients with ADPKD. Although further research is needed into, transfusion protocols, adjunctive therapies, such as TAE and research into timing of nephrectomy are still needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11845-024-03778-3","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T18:02:37Z","timestamp":1723485757000},"page":"2935-2939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Native nephrectomies in patients with autosomal dominant polycystic kidney disease: retrospective cohort study"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6676-7971","authenticated-orcid":false,"given":"Richard Edmund","family":"Hogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"McHale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Paul","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhussein","family":"Elhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor James","family":"Kilkenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponnusamy","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"3778_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1056\/NEJM199307293290508","volume":"329","author":"PA Gabow","year":"1993","unstructured":"Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329:332\u2013342. https:\/\/doi.org\/10.1056\/NEJM199307293290508","journal-title":"N Engl J Med"},{"key":"3778_CR2","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/ki.2014.120","volume":"86","author":"EM Spithoven","year":"2014","unstructured":"Spithoven EM, Kramer A, Meijer E et al (2014) Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease. Kidney Int 86:1244\u20131252. https:\/\/doi.org\/10.1038\/ki.2014.120","journal-title":"Kidney Int"},{"key":"3778_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1308\/003588411X582690","volume":"93","author":"P Patel","year":"2011","unstructured":"Patel P, Horsfield C, Compton F et al (2011) Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease. Ann R Coll Surg Engl 93:391\u2013395. https:\/\/doi.org\/10.1308\/003588411X582690","journal-title":"Ann R Coll Surg Engl"},{"key":"3778_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129317","volume":"10","author":"P Guo","year":"2015","unstructured":"Guo P, Xu W, Li H et al (2015) Laparoscopic nephrectomy versus open nephrectomy for patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis. PLoS ONE 10:e0129317. https:\/\/doi.org\/10.1371\/journal.pone.0129317","journal-title":"PLoS ONE"},{"key":"3778_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.6002\/ect.2020.0292","volume":"19","author":"A El Chediak","year":"2021","unstructured":"El Chediak A, Degheili JA, Khauli RB (2021) Genitourinary interventions in autosomal dominant polycystic kidney disease: clinical recommendations for urologic and transplant surgeons. Exp Clin Transplant 19:95\u2013103. https:\/\/doi.org\/10.6002\/ect.2020.0292","journal-title":"Exp Clin Transplant"},{"key":"3778_CR6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0272-6386(00)70021-7","volume":"35","author":"MD Dunn","year":"2000","unstructured":"Dunn MD, Portis AJ, Elbahnasy AM et al (2000) Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease. Am J Kidney Dis 35:720\u2013725. https:\/\/doi.org\/10.1016\/S0272-6386(00)70021-7","journal-title":"Am J Kidney Dis"},{"key":"3778_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101622","volume":"8","author":"A Maxeiner","year":"2019","unstructured":"Maxeiner A, Bichmann A, Oberl\u00e4nder N et al (2019) Native nephrectomy before and after renal transplantation in patients with autosomal dominant polycystic kidney disease (ADPKD). J Clin Med 8:1622. https:\/\/doi.org\/10.3390\/jcm8101622","journal-title":"J Clin Med"},{"key":"3778_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2021.100652","volume":"36","author":"J Xu","year":"2022","unstructured":"Xu J, D\u2019Souza K, Lau NS et al (2022) Staged versus concurrent native nephrectomy and renal transplantation in patients with autosomal dominant polycystic kidney disease: a systematic review. Transplant Rev 36:100652. https:\/\/doi.org\/10.1016\/j.trre.2021.100652","journal-title":"Transplant Rev"},{"key":"3778_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.5500\/wjt.v12.i9.310","volume":"12","author":"RA Gadelkareem","year":"2022","unstructured":"Gadelkareem RA, Abdelgawad AM, Mohammed N (2022) Simultaneous kidney transplantation and ipsilateral native nephrectomy in patients with autosomal dominant polycystic kidney disease. World J Transplant 12:310\u2013312. https:\/\/doi.org\/10.5500\/wjt.v12.i9.310","journal-title":"World J Transplant"},{"key":"3778_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1464-410X.2010.09938.x","volume":"108","author":"MA Kirkman","year":"2011","unstructured":"Kirkman MA, van Dellen D, Mehra S et al (2011) Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation? BJU Int 108:590\u2013594. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09938.x","journal-title":"BJU Int"},{"key":"3778_CR11","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.transproceed.2007.07.035","volume":"39","author":"P Nunes","year":"2007","unstructured":"Nunes P, Mota A, Alves R et al (2007) Simultaneous renal transplantation and native nephrectomy in patients with autosomal-dominant polycystic kidney disease. Transplant Proc 39:2483\u20132485. https:\/\/doi.org\/10.1016\/j.transproceed.2007.07.035","journal-title":"Transplant Proc"},{"key":"3778_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000554","volume":"1","author":"FT Chebib","year":"2015","unstructured":"Chebib FT, Prieto M, Yeonsoon J et al (2015) Native nephrectomy in renal transplant recipients with autosomal-dominant polycystic kidney disease. Transplant Direct 1:e43. https:\/\/doi.org\/10.1097\/TXD.0000000000000554","journal-title":"Transplant Direct"},{"key":"3778_CR13","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.transproceed.2020.01.135","volume":"52","author":"M Akabane","year":"2020","unstructured":"Akabane M, Nakamura Y, Miki K et al (2020) Effectiveness of nephrectomy and transcatheter arterial embolization before kidney transplantation in autosomal dominant polycystic kidney disease. Transplant Proc 52:1680\u20131683. https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.135","journal-title":"Transplant Proc"},{"key":"3778_CR14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s00270-018-1890-7","volume":"41","author":"W Ye","year":"2018","unstructured":"Ye W, Voss MD, Athreya S (2018) Volume reduction in enlarged kidneys in autosomal dominant polycystic kidney disease (ADPKD) prior to renal transplant with transcatheter arterial embolization (TAE): a systematic review and meta-analysis. Cardiovasc Intervent Radiol 41:828\u2013834. https:\/\/doi.org\/10.1007\/s00270-018-1890-7","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3778_CR15","doi-asserted-by":"publisher","unstructured":"Lyu JC, Du CK, Zhu YC (2024) Comparison between retroperitoneal laparoscopic nephrectomy and traditional open nephrectomy to treat polycystic kidney disease before kidney transplantation. Urol J 21:74\u201379. https:\/\/doi.org\/10.22037\/uj.v20i.7826","DOI":"10.22037\/uj.v20i.7826"},{"key":"3778_CR16","doi-asserted-by":"publisher","DOI":"10.4111\/icu.2018.59.4.238","volume":"59","author":"K Chen","year":"2018","unstructured":"Chen K, Tan YG, Tan D et al (2018) Predictors and outcomes of laparoscopic nephrectomy in autosomal dominant polycystic kidney disease. Investig Clin Urol 59:238. https:\/\/doi.org\/10.4111\/icu.2018.59.4.238","journal-title":"Investig Clin Urol"},{"key":"3778_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000513168","volume":"145","author":"AE Lubennikov","year":"2021","unstructured":"Lubennikov AE, Petrovskii NV, Krupinov GE et al (2021) Bilateral nephrectomy in patients with autosomal dominant polycystic kidney disease and end-stage chronic renal failure. Nephron 145:164\u2013170. https:\/\/doi.org\/10.1159\/000513168","journal-title":"Nephron"},{"key":"3778_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5489\/cuaj.2097","volume":"8","author":"RK Bansal","year":"2014","unstructured":"Bansal RK, Kapoor A (2014) Laparoscopic nephrectomy for massive polycystic kidney disease: updated technique and outcomes. Can Urol Assoc J 8:341. https:\/\/doi.org\/10.5489\/cuaj.2097","journal-title":"Can Urol Assoc J"},{"key":"3778_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000536245","volume":"148","author":"AM Drake","year":"2024","unstructured":"Drake AM, Paynter JA, Yim A et al (2024) Prevalence of renal neoplasia in autosomal dominant polycystic kidney disease: systematic review and meta-analysis. Nephron 148:457\u2013467. https:\/\/doi.org\/10.1159\/000536245","journal-title":"Nephron"},{"key":"3778_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2215\/CJN.00020112","volume":"8","author":"GT Obrador","year":"2013","unstructured":"Obrador GT, Macdougall IC (2013) Effect of red cell transfusions on future kidney transplantation. Clin J Am Soc Nephrol 8:852\u2013860. https:\/\/doi.org\/10.2215\/CJN.00020112","journal-title":"Clin J Am Soc Nephrol"},{"key":"3778_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.eururo.2011.10.033","volume":"61","author":"D Mitropoulos","year":"2012","unstructured":"Mitropoulos D, Artibani W, Graefen M et al (2012) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol 61:341\u2013349. https:\/\/doi.org\/10.1016\/j.eururo.2011.10.033","journal-title":"Eur Urol"},{"key":"3778_CR22","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/j.1464-410X.2012.11721.x","volume":"111","author":"GJ Vricella","year":"2013","unstructured":"Vricella GJ, Finelli A, Alibhai SMH et al (2013) The true risk of blood transfusion after nephrectomy for renal masses: a population-based study. BJU Int 111:1294\u20131300. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11721.x","journal-title":"BJU Int"},{"key":"3778_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4293\/108680813X13654754535719","volume":"17","author":"M Eng","year":"2013","unstructured":"Eng M, Jones CM, Cannon RM, Marvin MR (2013) Hand-assisted laparoscopic nephrectomy for polycystic kidney disease. JSLS 17:279\u2013284. https:\/\/doi.org\/10.4293\/108680813X13654754535719","journal-title":"JSLS"},{"key":"3778_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4293\/108680812X13462882736178","volume":"16","author":"G Verhoest","year":"2012","unstructured":"Verhoest G, Delreux A, Mathieu R et al (2012) Transperitoneal laparoscopic nephrectomy for autosomal dominant polycystic kidney disease. JSLS 16:437\u2013442. https:\/\/doi.org\/10.4293\/108680812X13462882736178","journal-title":"JSLS"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03778-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03778-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03778-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T23:04:50Z","timestamp":1734995090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03778-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3778"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03778-3","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"8 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was sought via the institution\u2019s IRB at Beaumont Hospital (CA2022\/074); all data was retrospective, already available and anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}